Gallium-68: Production and Imaging Agent Development - Velikyan, Irina
38,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Gallium-68 is of practical interest for clinical positron emission tomography (PET), a non-invasive imaging technique of high resolution, sensitivity and accurate quantification. The use of PET in nuclear medicine depends on the accessibility of imaging agents. Gallium-68 is suitable for complexation with chelators, either naked or conjugated to various molecules with potential for the development of agents for targeted, non-targeted and pre-targeted imaging. It is readily available from a 68Ge/68Ga generator and its chemistry is straightforward and amenable to automated and kit type…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Gallium-68 is of practical interest for clinical positron emission tomography (PET), a non-invasive imaging technique of high resolution, sensitivity and accurate quantification. The use of PET in nuclear medicine depends on the accessibility of imaging agents. Gallium-68 is suitable for complexation with chelators, either naked or conjugated to various molecules with potential for the development of agents for targeted, non-targeted and pre-targeted imaging. It is readily available from a 68Ge/68Ga generator and its chemistry is straightforward and amenable to automated and kit type production. Its decay mode and half-life provide high quality PET images and allow sequential repetitive examinations. The production of agents with high specific radioactivity might be of great benefit for clinical practice and may promote personalized medicine. The book presents techniques for the radionuclide production and labelling with high specific radioactivity, development of various imagingagents and their biological, clinical and technological applications. The importance of specific radioactivity is demonstrated and discussed.
Autorenporträt
received her PhD in radiopharmaceutical chemistry from Uppsala University, Sweden, where she currently teaches courses and supervises students. She works as a Scientist at Uppsala Applied Science Lab, GE Healthcare conducting research in radiopharmaceutical development for nuclear medicine.